{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-011278","form_type":"8-K","ticker":"ALNY","cik":"0001178670","company_name":"ALNYLAM PHARMACEUTICALS, INC.","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.575520+00:00","generated_at":"2026-06-06T21:05:28.566203+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Alnylam EVP & Chief Legal Officer Indrani Franchini to depart March 1, 2024","bullets":["Indrani L. Franchini to transition from EVP, Chief Legal Officer and Secretary effective March 1, 2024.","Mutual agreement reached on January 12, 2024; severance terms to be formalized in a written agreement on or before the separation date.","No replacement has been named for the Chief Legal Officer and Secretary role."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-011278","json":"https://secwatch.observer/filing/0001193125-24-011278.json","markdown":"https://secwatch.observer/filing/0001193125-24-011278.md","text":"https://secwatch.observer/filing/0001193125-24-011278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178670/000119312524011278/0001193125-24-011278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178670/000119312524011278/d701085d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:05:28.566203+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7617083c78","claim":"Indrani L. Franchini changed role as Executive Vice President, Chief Legal Officer and Secretary at ALNYLAM PHARMACEUTICALS, INC..","evidence_excerpt":"On January 12, 2024, Alnylam Pharmaceuticals, Inc. (the “Company”) and Indrani L. Franchini agreed that she would transition from her role as the Company’s Executive Vice President, Chief Legal Officer and Secretary, effective as of March 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178670/000119312524011278/0001193125-24-011278-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transition"},{"label":"Role","value":"Executive Vice President, Chief Legal Officer and Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}